Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Pemafibrate
Cat. No.:
0225LY-0825
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Pemafibrate is a highly specialized agonist for PPAR-alpha, showing an EC50 of 1 nM.
Synonym:
(R)-K-13675; 848259-27-8; Pemafibrate; Parmodia; Pemafibrate [INN]; (R)-K-13675; UNII-17VGG92R23; K-13675, (R)-; 17VGG92R23; (R)-K 13675; (R)-2-(3-((benzo[d]oxazol-2-yl(3-(4-methoxyphenoxy)propyl)amino)methyl)phenoxy)butanoic acid; CHEMBL247951; K-877; DTXSID00233891; (2R)-2-[3-({1,3-benzoxazol-2-yl[3-(4-methoxyphenoxy)propyl]amino}methyl)phenoxy]butanoic acid; (2R)-2-[3-[[1,3-benzoxazol-2-yl-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid; (2~{R})-2-[3-[[1,3-benzoxazol-2-yl-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid
CAS No.:
848259-27-8
Compound CID:
11526038
Formula:
C28H30N2O6
Formula Weight:
490.55
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Pemafibrate can be used in cardiovascular research to evaluate the effects of highly selective PPAR alpha modulation on lipid metabolism.
Library Information
Target:
PPAR
Receptor:
PPARα ; PPARγ
Pathways:
Metabolism; DNA damage/DNA repair
Plate Number:
AOCL-11
Plate Location:
f4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
